论文部分内容阅读
目的为了对~(125)I放射免疫分析药盒使用活动实行豁免管理,促进~(125)I放射免疫分析药盒能够在二级医疗机构及边远地区医疗机构发挥作用。方法通过对~(125)I放射免疫分析药盒使用市场调查,以及活动场所和放射性“三废”的监测及分析。结果~(125)I放射免疫分析药盒使用活动中的年个人有效剂量,年集体有效剂量、放射性“三废”、日操作量满足《电离辐射防护与辐射源安全基本标准》中的豁免准则和相关条件。结论对~(125)I放射免疫分析药盒使用活动实行豁免管理能够保障人员和环境的安全。
Objective To promote exemption management of ~ (125) I radioimmunoassay kit and to promote 125I radioimmunoassay kit in secondary medical institutions and remote medical institutions. Methods The market survey of 125I radioimmunoassay kit, as well as the monitoring and analysis of the activity sites and radioactive “three wastes” were conducted. Results The annual effective dose, annual effective dose, radioactive “three wastes” and daily manipulations of ~ (125) I radioimmunoassay kit met the exemption from “Basic Standard of Ionizing Radiation Protection and Radiation Source Safety” Guidelines and related conditions. Conclusion The exemption management of ~ (125) I radioimmunoassay kit can protect people and the environment.